147 related articles for article (PubMed ID: 16800253)
21. Biological activities of a novel selective oestrogen receptor modulator derived from raloxifene (Y134).
Ning M; Zhou C; Weng J; Zhang S; Chen D; Yang C; Wang H; Ren J; Zhou L; Jin C; Wang MW
Br J Pharmacol; 2007 Jan; 150(1):19-28. PubMed ID: 17115070
[TBL] [Abstract][Full Text] [Related]
22. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
[TBL] [Abstract][Full Text] [Related]
23. Estrogen-induced stromal cell-derived factor-1 (SDF-1/Cxcl12) expression is repressed by progesterone and by Selective Estrogen Receptor Modulators via estrogen receptor alpha in rat uterine cells and tissues.
Glace L; Grygielko ET; Boyle R; Wang Q; Laping NJ; Sulpizio AC; Bray JD
Steroids; 2009; 74(13-14):1015-24. PubMed ID: 19665469
[TBL] [Abstract][Full Text] [Related]
24. Perinatal Exposure to Bisphenol A or Diethylstilbestrol Increases the Susceptibility to Develop Mammary Gland Lesions After Estrogen Replacement Therapy in Middle-Aged Rats.
Gomez AL; Delconte MB; Altamirano GA; Vigezzi L; Bosquiazzo VL; Barbisan LF; Ramos JG; Luque EH; Muñoz-de-Toro M; Kass L
Horm Cancer; 2017 Apr; 8(2):78-89. PubMed ID: 28078498
[TBL] [Abstract][Full Text] [Related]
25. Hormone interactions confer specific proliferative and histomorphogenic responses in the porcine mammary gland.
Horigan KC; Trott JF; Barndollar AS; Scudder JM; Blauwiekel RM; Hovey RC
Domest Anim Endocrinol; 2009 Aug; 37(2):124-38. PubMed ID: 19497700
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Ki-67 antigen expression in the vaginal epithelium of castrated female rats treated with raloxifene and tamoxifen: a comparative study.
de Moura-Leal AC; de Sousa JM; de Moura-Leal H; de Sousa GV; Alencar AP; Borges US; Pinto GR; da Silva BB
Gynecol Endocrinol; 2016 Jun; 32(6):453-6. PubMed ID: 27199299
[TBL] [Abstract][Full Text] [Related]
27. Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model.
Raafat AM; Li S; Bennett JM; Hofseth LJ; Haslam SZ
J Cell Physiol; 2001 Apr; 187(1):81-9. PubMed ID: 11241352
[TBL] [Abstract][Full Text] [Related]
28. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
29. Proliferative and estrogenic sensitivity of the mammary gland are modulated by isoflavones during distinct periods of adolescence.
Molzberger AF; Soukup ST; Kulling SE; Diel P
Arch Toxicol; 2013 Jun; 87(6):1129-40. PubMed ID: 23288143
[TBL] [Abstract][Full Text] [Related]
30. The effects of alone and combination tamoxifen, raloxifene and estrogen on lipid profile and atherogenic index of ovariectomized type 2 diabetic rats.
Ebrahimi MN; Khaksari M; Sepehri G; Karam GA; Raji-Amirhasani A; Azizian H
Life Sci; 2020 Dec; 263():118573. PubMed ID: 33058909
[TBL] [Abstract][Full Text] [Related]
31. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats.
Lotinun S; Westerlind KC; Turner RT
J Endocrinol; 2001 Jul; 170(1):165-74. PubMed ID: 11431149
[TBL] [Abstract][Full Text] [Related]
32. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
[TBL] [Abstract][Full Text] [Related]
33. Effect of hormone replacement therapy on the elemental contents of uterine tissue.
Ynsa MD; Ager FJ; Millán JC; Gómez-Zubelbia MA; Pinheiro T
Biol Trace Elem Res; 2004 Oct; 101(1):37-46. PubMed ID: 15516701
[TBL] [Abstract][Full Text] [Related]
34. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression.
Zhou J; Ng S; Adesanya-Famuiya O; Anderson K; Bondy CA
FASEB J; 2000 Sep; 14(12):1725-30. PubMed ID: 10973921
[TBL] [Abstract][Full Text] [Related]
35. Raloxifene effects upon the neuronal system controlling sexual receptivity in female rats.
Pinilla L; Barreiro ML; Tena-Sempere M; Aguilar E
Neurosci Lett; 2002 Sep; 329(3):285-8. PubMed ID: 12183032
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen impairs prepubertal mammary development and alters expression of estrogen receptor α (ESR1) and progesterone receptors (PGR).
Tucker HL; Parsons CL; Ellis S; Rhoads ML; Akers RM
Domest Anim Endocrinol; 2016 Jan; 54():95-105. PubMed ID: 26619291
[TBL] [Abstract][Full Text] [Related]
37. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland.
Russo J; Ao X; Grill C; Russo IH
Breast Cancer Res Treat; 1999 Feb; 53(3):217-27. PubMed ID: 10369068
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.
Naves-Díaz M; Carrillo-López N; Rodríguez-Rodríguez A; Braga S; Fernández-Coto T; Lopez-Novoa JM; López-Hernández F; Cannata-Andía JB
Menopause; 2010 Jul; 17(4):766-71. PubMed ID: 20386345
[TBL] [Abstract][Full Text] [Related]
39. The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health?
Labrie F; El-Alfy M; Berger L; Labrie C; Martel C; Bélanger A; Candas B; Pelletier G
Endocrinology; 2003 Nov; 144(11):4700-6. PubMed ID: 12960051
[TBL] [Abstract][Full Text] [Related]
40. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
Frolik CA; Bryant HU; Black EC; Magee DE; Chandrasekhar S
Bone; 1996 Jun; 18(6):621-7. PubMed ID: 8806005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
